共查询到20条相似文献,搜索用时 36 毫秒
1.
2.
目的 探讨CT灌注成像评价家犬急性缺血性脑梗死模型的价值.方法 12只健康雄性家犬按照随机数字表法分为模型组6只与对照组6只.模型组采用介入技术方法 建立急性缺血性脑梗死模型,对照组不建立模型.造模后1周对家犬进行CT灌注成像评价,测定感兴趣区的脑血流量(CBF)、脑血容量(CBV)、局部灌注达到峰值时间(TTP);并... 相似文献
3.
4.
Rai AT Carpenter JS Peykanu JA Popovich T Hobbs GR Riggs JE 《The Journal of emergency medicine》2008,35(3):287-292
The objective of this study was to determine the utility of computed tomography perfusion (CTP) scans in diagnosing acute ischemic stroke (AIS). CTP abnormalities in two contiguous supratentorial levels were correlated with diffusion weighted image (DWI) abnormalities on magnetic resonance imaging (the standard for stroke diagnosis) performed within 1 week in 422 suspected acute ischemic strokes. Of 157 AIS confirmed by DWI, 78 showed CTP abnormalities (sensitivity 49.7%). All of these examinations were performed with a mean of 35 min from the initial emergency department neurological examination. Excluding small non-vascular territory strokes left 77 AIS with a total volume of infarcted tissue of more than 5 cc by DWI. Of these, 71 showed CTP abnormalities (sensitivity 92.2%). Of the 265 patients without AIS, none showed CTP abnormalities (specificity 100%). CTP is a rapid, readily available and effective method of diagnosing AIS in clinical practice, particularly the major intracranial vessel strokes that result in a more devastating outcome. 相似文献
5.
6.
低分子肝素治疗进展型缺血性脑卒中(脑血栓)的临床研究 总被引:4,自引:0,他引:4
目的 研究低分子肝素(速避凝)治疗进展型缺血性脑卒中的疗效及安全性。方法 60例发病时间超过24小时,已不适合溶栓治疗的进展型缺血性脑卒中患,随机分为低分子肝素治疗组和低分子右旋糖酐对照组各30例。两组均于治疗前和治疗后14日作神经功能缺损评分,结合治疗后患的病残程度评定疗效。结果 治疗组总有效率为90.0%,而对照组为66.7%,两组比较有显性差异(P<0.05)。且治疗组未发现有明显的不良反应。结论 低分子肝素治疗进展型缺血性脑卒中是比较安全、有效的方法。 相似文献
7.
急性缺血性卒中已经成为我国第一大致残、致死性疾病。随着以荷兰血管内治疗急性缺血性卒中多中心随机临床试验为代表的五大试验结果公布,机械取栓已经成为治疗颅内大血管闭塞引起的急性缺血性脑卒中的主要手段,迎来了急性脑梗死机械取栓治疗的新时代。目前机械取栓的主要装置有Merci取栓装置、Penumbra吸栓装置、Solitaire™FR支架、Revive SE支架、Trevo支架和Aperio®支架等,针对血管栓塞部位及血管条件要选择不同类型的取栓装置,同时采用不同的取栓技术,比如ADAPT技术、Solumbra技术、Advance技术、SAVE技术、SWIM技术等,才能提高血管再通率,降低并发症。 相似文献
8.
9.
目的 评估AIS-APS评分(acute ischemic stroke-associated pneumonia score)预测急性缺血性卒中7d内发生卒中相关性肺炎(stroke-associated pneumonia,SAP)风险的应用价值.方法 采用前瞻性、连续性队列研究的方法,应用AIS-APS评分法对2013年7月至2015年4月北京同仁医院入选的309例急性缺血性卒中患者进行评分,根据患者7d内SAP的发生率,分析AIS-APS评分法预测急性缺血性卒中发生SAP的作用.并检测量表的信度和结构效度.结果 总计有12.9%(40例)急性缺血性卒中患者罹患肺炎.依据AIS-APS评分法:极高危组28~ 35分、高危组21 ~ 27分、中度危险组14~20分、低危险组7~13分和极低危险组0~6分的患者7d内发生SAP的比率分别是90.8%、66.5%、23.5%、8.32%、3.85%.量表和各维度的Cronbach's α系数均大于0.7.结构效度检测结果与量表理想的结构相一致.结论 AIS-APS评分法是一种操作性强的,能对卒中者SAP罹患风险进行分层评价的工具,对急性缺血性卒中相关性肺炎的预测具有较好的信度、效度.利用AIS-APS评分法有助于临床工作中快速筛选出SAP高危患者,对SAP患者可予及早诊断和早期干预. 相似文献
10.
Modern imaging of the infarct core and the ischemic penumbra in acute stroke patients: CT versus MRI
《Expert review of cardiovascular therapy》2013,11(4):395-403
Thrombolysis has become an approved therapy for acute stroke. However, many stroke patients do not benefit from such treatment, since the presently used criteria are very restrictive, notably with respect to the accepted time window. Even so, a significant rate of intracranial hemorrhage still occurs. Conventional cerebral computed tomography (CT) without contrast has been proposed as a selection tool for acute stroke patients. However, more-modern MRI and CT techniques, referred to as diffusion- and perfusion-weighted imaging and perfusion-CT, have been introduced, which afford a comprehensive noninvasive survey of acute stroke patients as soon as their emergency admission, with accurate demonstration of the site of arterial occlusion and its hemodynamic and pathophysiological repercussions for the brain parenchyma. The objective of this article is to present the advantages and drawbacks of CT and MRI in the evaluation of acute stroke patients. 相似文献
11.
Amelia Nelson Gregory Kelly Richard Byyny Catherine Dionne Candice Preslaski Kevin Kaucher 《The American journal of emergency medicine》2019,37(2):344-348
Introduction
Acute ischemic stroke is a leading cause of disability in the United States. Treatment is aimed at reducing impact of cerebral clot burden and life-long disability. Traditional fibrinolytic treatment with recombinant tissue plasminogen activator (tPA) has shown to be effective but at high risk of major bleeding. Multiple studies have evaluated tenecteplase as an alternative to tPA.Objective
This review evaluates literature and utility of tenecteplase for treatment of acute ischemic stroke.Discussion
Tenecteplase is modified, third generation fibrinolytic with greater specificity for fibrin bound clots. Current data in acute myocardial infarction suggest decreased bleeding events compared to alteplase. Multiple trials have investigated superiority of tenecteplase compared to tPA for treatment of acute ischemic stroke. Current guidelines designate tenecteplase as an alternative treatment for mild acute ischemic stroke patients based on recent literature.Conclusion
Recent emerging literature and limited recommendation guidance from governing medical societies leave many emergency medicine providers to weigh benefit versus risk of fibrinolytic therapy and tenecteplase's place in therapy. This review evaluates the available literature regarding tenecteplase and its utility in the treatment of acute ischemic stroke patients. 相似文献12.
For the diagnosis and precise treatment of acute ischemic stroke, predicting the final location and volume of lesions is of great clinical interest. Current deep learning-based prediction methods mainly use perfusion parameter maps, which can be calculated from spatio-temporal (4D) CT perfusion (CTP) imaging data, to estimate the tissue outcome of an acute ischemic stroke. However, this calculation relies on a deconvolution operation, an ill-posed problem requiring strong regularization and definition of an arterial input function. Thus, improved predictions might be achievable if the deep learning models were applied directly to acute 4D CTP data rather than perfusion maps. In this work, a novel deep spatio-temporal convolutional neural network is proposed for predicting treatment-dependent stroke lesion outcomes by making full use of raw 4D CTP data. By merging a U-Net-like architecture with temporal convolutional networks, we efficiently process the spatio-temporal information available in CTP datasets to make a tissue outcome prediction. The proposed method was evaluated on 147 patients using a 10-fold cross validation, which demonstrated that the proposed 3D+time model (mean Dice=0.45) significantly outperforms both a 2D+time variant of our approach (mean Dice=0.43) and a state-of-the-art method that uses perfusion maps (mean Dice=0.38). These results show that 4D CTP datasets include more predictive information than perfusion parameter maps, and that the proposed method is an efficient approach to make use of this complex data. 相似文献
13.
目的 探讨多时相CT血管造影(CTA)对急性缺血性脑卒中(AIS)患者侧支循环评估价值及溶栓治疗指导作用.方法 我院收治的AIS患者,选取其中接受重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗的120例患者为研究对象.治疗前均给予多时相CTA检查,根据影像学检查结果及Alberta卒中项目早期CT评分(ASPECT... 相似文献
14.
解读AAN发布的《DWI和PWI在缺血性卒中的诊断价值-循证指南》 总被引:2,自引:0,他引:2
近期,美国神经病学学会(AAN)治疗与技术评定小组发布了《磁共振扩散加权成像(DWI)和灌注加权成像(PWI)在缺血性卒中的诊断价值一循证指南》(以下简称《指南》),《指南》以循证医学证据为基础,对相关研究试验进行回顾分析,并得出具有指导意义的6条推荐意见。本文对《指南》的主要内容进行介绍,对其采用的相关循证医学依据进行解读。 相似文献
15.
目的 探究头颅CT血管造影(CTA)联合磁共振血管成像(MRA)在诊断急性缺血性脑卒中(AIS)中的应用价值.方法 回顾性选取2018年1月至2020年1月资阳市第一人民医院收治的57例疑似AIS患者,最终确诊42例,收集患者临床资料,所有患者均行数字减影血管造影(DSA)检查及头颅CTA、三维时间飞跃法磁共振血管成像... 相似文献
16.
17.
刘玉博 《影像研究与医学应用》2022,(1):4-6
目的:分析应用头颈部非创伤性血管成像技术(简称CT血管造影)(CT angiography,CTA)实施颈动脉狭窄诊断对于急性缺血性脑卒早期诊断的应用价值.方法:选取2020年5月—2021年5月宁津县人民医院收治的50例疑似颈动脉狭窄急性缺血性脑卒中患者,对入组患者均实施头颈部CTA扫描及颈部血管彩超,对比数字减影血... 相似文献
18.
杨红艳 《中华现代护理杂志》2011,17(11):1265-1268
目的 探讨不同中医征候急性缺血性脑卒中患者的心理问题,以指导临床护理人员进行相应的心理干预.方法 应用症状自评量表(SCL-90)对154例急性缺血性脑卒中住院患者进行心理调查,根据中医症候诊断进行相关分析.结果 急性缺血性脑卒中患者存在明显的心理问题;不同中医征候患者心理问题表现不同,"实证"和"虚证"患者在躯体化、强迫症状、抑郁、敌对方面的表现差异有统计学意义(P<0.01或P<0.05).结论 急性缺血性脑卒中患者存在明显的心理问题,征候虚实不同,临床表现各异,临床护理人员应重视对急性缺血性脑卒中患者的心理护理,并针对不同的证型给予相应的心理干预,以减轻患者的心理问题,改善预后. 相似文献
19.
Gentile NT Cernetich J Kanamalla US Kochan JP Reimer H Freeman B Jungreis C 《The Journal of emergency medicine》2012,43(2):308-315
Background
Acute ischemic stroke diagnosis and treatment are among the most challenging in Emergency Medicine. Perfusion computed tomography (CTP) can increase the sensitivity for detecting ischemic stroke and, especially with the addition of CT angiography (CTA), improve decision-making regarding thrombolytic therapy compared to non-contrast computed tomography (NCCT) alone. However, because acute stroke protocols do not generally include procedures for multimodal imaging, they are not commonly performed. In addition, there is concern that additional studies could delay or preclude therapy in patients otherwise eligible for thrombolytic therapy.Objectives
To demonstrate the feasibility of perfusion CTP and CTA in addition to NCCT of the brain in the emergency assessment of patients with acute ischemic stroke. Methods: Starting January 2008, multimodal (CTP and CTA) imaging was added to NCCT in the Emergency Department (ED) initial assessment of patients with stroke of ≤ 5 h duration. Over the subsequent 9 months, we measured the time from ED arrival to imaging and to recombinant tissue plasminogen activator (rt-PA) treatment and compared these times to patients evaluated with CT alone.Results
From January to October 2008, 95 patients had CTP and CTA studies in addition to NCCT for acute ischemic stroke. There were no differences between the average time to CT study or to rt-PA treatment between patients evaluated with multimodal CT imaging and patients assessed with NCCT alone.Conclusions
Combining CTP and CTA with NCCT is feasible and does not adversely increase the time to CT imaging or rt-PA treatment in patients with acute ischemic stroke. 相似文献20.
目的探讨代谢综合征与急性脑梗死患者预后之间的关系。方法观察自2008年1月至2014年1月691例急性脑梗死患者,按照1995年全国第4届脑血管病学术会议《临床疗效评定标准》进行预后评定,运用多因素回归分析评估代谢综合征与急性脑梗死患者预后之间的关系。结果 691例患者中,277例患者预后较差,代谢综合征与急性脑梗死预后之间联系显著,校正OR值(95%CI)为1.57(1.13~2.19),不良预后与代谢综合征包含的危险因素数量之间关系显著。结论代谢综合征与急性脑梗死不良预后关系显著。 相似文献